Skip to main content

Epidemiology and medical treatment of cholesterol gallstones: recurrence, post-dissolution management and the future

  • Chapter
Epidemiology and Prevention of Gallstone Disease

Abstract

The results of epidemiological studies, now based mainly on ultrasound screening, tell us that in developed societies the prevalence of gallstones is approximately 10%l .When combined with clinical assessment they also tell us that approximately two-thirds of gallstone carriers are unaware that they have stones2 3. In other words, the majority of gallstones diagnosed in this way are silent or asymptomatic. Indirect support for the concept that ‘the innocent gallstone is not a myth’4 comes from comparisons between prevalence rates for cholelithiasis and cholecystectomy rates in any given community. Even though the frequency with which cholecystectomy is carried out varies considerably from country to country5, and despite the fact that surgical removal of the gallbladder is now the most common abdominal operation performed in Western society6, it is clear that only a minority of gallstone carriers will ever come to surgery. By inference, therefore, the majority of patients with cholelithiasis are either unaware of their stones or have related symptoms which the patient, the doctor (or both) judge to be tolerable.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ingelfinger, F. J. (1968). Digestive disease as a national problem. V. Gallstones. Gastroenterology, 55, 102–104

    PubMed  CAS  Google Scholar 

  2. Ricci, G. (1983). The Grepco Study: aims, methodology and prevalence data. In Abstracts of International Workshop on Epidemiology and Prevention of Gallstone Disease, Rome, December 1983

    Google Scholar 

  3. Barbara, L. (1983). Epidemiology of gallstone disease: the Sirmione Study. In Abstracts of International Workshop on Epidemiology and Prevention of Gallstone Disease, Rome, December 1983

    Google Scholar 

  4. Gracie, W. A. and Ransohoff, D. F. (1982). The natural history of silent gallstones: the innocent gallstone is not a myth. N. Engl. J. Med., 307, 798–800

    Article  PubMed  CAS  Google Scholar 

  5. Fisher, M. M. (1979). Perspectives in gallstones. In Fisher, M. M., Goresky, C. A., Shaffer, E. A. and Strasberg, S. M. (eds.) Gallstones, pp. 1–17. ( New York: Plenum )

    Google Scholar 

  6. Holland, C. and Heaton, K. W. (1972). Increasing frequency of gallbladder operations in the Bristol clinical area. Br. Med. J., 3, 672–675

    Article  PubMed  CAS  Google Scholar 

  7. Lund, J. (1960). Surgical indications in cholelithiasis: prophylactic cholecystectomy elucidated on the basis of long-term follow-up on 526 non operated cases. Ann. Surg., 151, 153–162

    Article  PubMed  CAS  Google Scholar 

  8. Wenckert, A. and Robertson, B. (1966). The natural course of gallstone disease. Eleven-year review of 871 nonoperated cases. Gastroenterology, 50, 376–381

    PubMed  CAS  Google Scholar 

  9. Donaldson, R. M. Jr (1982). Advice for the patient with ‘silent’ gallstones. N. Engl J. Med., 307, 815–817

    Article  PubMed  Google Scholar 

  10. Dowling, R. H. (1982). Cholelithiasis: medical treatment. Clin. Gastroenterol., 12, 125–178

    Google Scholar 

  11. Northfield, T. C., LaRusso, N. F., Hofmann, A. F. and Thistle, J. L. (19 75). Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects. Gut, 16, 12–17

    Article  PubMed  CAS  Google Scholar 

  12. von Bergmann, K., Gutsfeld, M., Schulze-Hagen, K. and von Unruh, G. (1979). Effects of ursodeoxycholic acid on biliary lipid secretion in patients with radiolucent gallstones. In Paumgartner, G., Stiehl, A. and Gerok, W. (eds.) Biological Effects of Bile Acids, pp. 61–66. ( Lancaster: MTP Press )

    Google Scholar 

  13. Thistle, J. L. and Schoenfield, L. J. (1971). Induced alterations in composition of bile of persons having cholelithiasis. Gastroenterology, 61, 488–496

    PubMed  CAS  Google Scholar 

  14. Maton, P. N., Murphy, G. M. and Dowling, R. H. (1977). Ursodeoxycholic acid treatment of gallstones. Dose-response study and possible mechanism of action. Lancet, 2, 1297–1301

    Article  PubMed  CAS  Google Scholar 

  15. Schoenfield, L. J., Lachin, J. M., the NCGS Steering Committee and the NCGS Group (1981). National Cooperative Gallstone Study: A controlled trial of the efficacy and safety of chenodeoxycholic acid for dissolution of gallstones. Ann. Intern. Med., 95, 257–282

    PubMed  CAS  Google Scholar 

  16. Leuschner, U. (1977). Dissolution of biliary cholesterol calculi using chenodeoxycholic acid. Internist, 18, 114–115

    PubMed  CAS  Google Scholar 

  17. Leuschner, U., Leuschner, M. and Stromm, W. D. (1982). Our 10 years’ experience in gallstone dissolution. Comparison with the National Cooperative Gallstone (NCGS, USA) and the Tokyo Cooperative Gallstone Study (TCGS, Japan). Gastroenterology, 80, 1113 (abstract)

    Google Scholar 

  18. Maton, P. N., Iser, J. H., Reuben, A., Saxton, H. M., Murphy, G. M. and Dowling, R. H. (1982). The final outcome of CDCA-treatment in 12 5 patients with radiolucent gallstones: factors influencing efficacy withdrawal, symptoms and side effects and post-dissolution recurrence. Medicine (Baltimore), 61, 85–96

    Google Scholar 

  19. Dowling, R. H., Hofmann, A. F. and Barbara, L. (1978). Workshop on Ursodeoxycholic Acid. ( Lancaster: MTP Press )

    Google Scholar 

  20. Bachrach, W. H. and Hofmann, A. F. (1982). Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis: a review. Dig. Dis. Sci., 27, 737–761

    Article  PubMed  CAS  Google Scholar 

  21. Tokyo Cooperative Gallstone Study Group (1980). Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. Gastroenterologic, 78, 542–548

    Google Scholar 

  22. Bateson, M. C., Bouchier, I. A. D., Trash, D. B., Maudgal, D. P. and Northfield, T. C. (1981). Calcification of radiolucent gall stones during treatment with ursodeoxycholic acid. Br. Med. J., 283, 645–656

    Article  CAS  Google Scholar 

  23. Raedsch, R., Stiehl, A. and Cyzgan, P. (1983). Ursodeoxycholic acid and gallstone calcification. Lancet, 2, 1296 (Letter to editor)

    Google Scholar 

  24. Gleeson, D., Ruppin, D. C., Murphy, G. M. and Dowling, R. H. (1983). Second look at ursodeoxycholic acid (UDCA): high efficacy for partial but low efficacy for complete gallstone dissolution, and a high rate of acquired stone opacification. Gut, 24, A999–A1000 (abstract)

    Google Scholar 

  25. Whiting, M., Jarvinen, V. and Watts, J. (1980). Chemical composition of gallstones resistant to dissolution therapy with chenodeoxycholic acid. Gut, 21, 1077–1081

    Article  PubMed  CAS  Google Scholar 

  26. Sarva, R., Farivar, S., Fromm, H. and Poller, W. (1981). Study of the sensitivity and specificity of computerized tomography in the detection of calcified gallstones which appear radiolucent by conventional roentgenography. Gastrointest. Radiol., 6, 165–167

    Article  PubMed  CAS  Google Scholar 

  27. Roda, E., Bazzoli, F. and Labate, A. M. M. (1982). Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study. Hepatology, 2, 804–810

    Article  PubMed  CAS  Google Scholar 

  28. Fromm, H., Roat, J. W., Gonzalez, V., Sarva, R. P. and Farivar, S. (1983). Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. Gastroenterology, 85, 1257–1264

    PubMed  CAS  Google Scholar 

  29. Ruppin, D. C., Maton, P. N., Williams, G. V., Merdith, T. J., Murphy, G. M., and Dowling, R. H. (1982). Ursotherapy for cholesterol gallstones? Ital. J. Gastroenterol., 15, (abstract; in press)

    Google Scholar 

  30. Somerville, K. W., Rose, D. H. and Bell, G. D. (1982). Gall-stone dissolution and recurrence: are we being misled? Br. Med. J., 284, 1295–1297

    Article  CAS  Google Scholar 

  31. Shapero, T. F., Rosen, I. E., Milson, S. R. and Fisher, M. M. (1982). Discrepancy between ultrasound and oral cholecystography in the assessment of gallstone dissolution. Hepatology, 2, 587–590.

    Article  PubMed  CAS  Google Scholar 

  32. Baddley, H., Nolan, D. J. and Slamon, P. R. (1978). Radiological Atlas of Biliary and Pancreatic Disease. ( Aylesbury: HM&M )

    Google Scholar 

  33. Jacobus, D. P., Trout, J. R., Greenwell, B. E., Schoenfield, L. J. and Lachin, J. M. (1983). The natural history and the therapeutic response to Chenodiol in patients with floatable stones in the National Co-operative Gallstone Study (NCGS). Gastroenterology, 84, 1197 (abstract)

    Google Scholar 

  34. Dumont, M., Erlinger, S. and Uchman, S. (1980). Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat. Possible role of bicarbonate transport. Gastroenterology, 79, 82–89

    PubMed  CAS  Google Scholar 

  35. Batta, A. K., Salen, G., Shefer, S., Tint, G. S. and Dayal, B. (1982). The effect of tauroursodeoxycholic acid and taurine supplementation on biliary bile açid composition. Hepatology, 2, 811–816

    Article  PubMed  CAS  Google Scholar 

  36. Bell, G. D., Dowling, R. H., Whitney, B. and Sutor, D. J. (1975). The value of radiology in predicting gallstone type when selecting patients for medical treatment. Gut, 16, 359–364.

    Article  PubMed  CAS  Google Scholar 

  37. Trotman, B. W., Petrella, E. J., Soloway, R. D., Sanchez, H., Morris, T. A., III and Miller, W. T. (1975). Evaluation of radiographic lucency or opaqueness of gallstones as a means of identifying cholesterol or pigment stones. Correlation of lucency or opaqueness with calcium and mineral. Gastroenterology, 68, 1563–1566

    PubMed  CAS  Google Scholar 

  38. Bruusgaard, A., Sorensen, T. I. A., Justensen, T. and Krag, E. (1976). Bile acid metabolism after jejunoileal bypass operation for obesity. Scand. J. Gastroenterol., 11, 833–838

    PubMed  CAS  Google Scholar 

  39. Maton, P. N., Murphy, G. M. and Dowling, R. H. (1980). Lack of response to chenodeoxycholic acid in obese and non-obese patients. Gut, 21, 1082–1086

    Article  PubMed  CAS  Google Scholar 

  40. Fisher, M. M., Roberts, E. A., Rosen, I. E. and Wilson, S. R. (1982). The efficacy of chenodeoxycholic acid in the dissolution of gallstones. In Bile Acids and Cholesterol in Health and Disease. I. Abstracts, 7th International Bile Acid Meeting, Basel, pp. 256–257

    Google Scholar 

  41. Gleeson, D., Ruppin, D. C. and Dowling, R. H. (1983). British Gallstone Study Group (BGSG) post-dissolution trial: interim report on overall recurrence rates and discrepancies between ultrasonography (US) and oral cholecystography (OCG). Gut, 24, A1006 (abstract)

    Google Scholar 

  42. Ruppin, D. C. and Dowling, R. H. (1982). Is recurrence inevitable after gallstone dissolution by bile acid treatment? Lancet, 1, 181–185

    Article  PubMed  CAS  Google Scholar 

  43. Toulet, J., Rousselet, J., Viteau, J.-M., Duchon, Y., Pagniez, R., Samain, B. and Vienne, J.-L. (1983). Récidives et prévention des récidives après dissolution de la lithiase vésiculaire par l’acide chénodésoxycholique chez 22 patients. Gastroenterol. Clin. Biol., 7, 605–609

    PubMed  CAS  Google Scholar 

  44. Thistle, J. L. (1981). Medical treatment of gallstones. Pract. Gastroenterol., 5, 31–38

    Google Scholar 

Download references

Authors

Editor information

L. Capocaccia G. Ricci F. Angelico M. Angelico A. F. Attili

Rights and permissions

Reprints and permissions

Copyright information

© 1984 MTP Press Limited

About this chapter

Cite this chapter

Dowling, R.H. (1984). Epidemiology and medical treatment of cholesterol gallstones: recurrence, post-dissolution management and the future. In: Capocaccia, L., Ricci, G., Angelico, F., Angelico, M., Attili, A.F. (eds) Epidemiology and Prevention of Gallstone Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-5606-3_17

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-5606-3_17

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-8972-2

  • Online ISBN: 978-94-009-5606-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics